XFOR Ebit from 2010 to 2024

XFOR Stock  USD 1.01  0.03  3.06%   
X4 Pharmaceuticals EBIT yearly trend continues to be relatively stable with very little volatility. EBIT is likely to grow to about -102.1 M this year. During the period from 2010 to 2024, X4 Pharmaceuticals EBIT destribution of quarterly values had r-value of (0.94) from its regression line and median of (32,262,000). View All Fundamentals
 
EBIT  
First Reported
2016-12-31
Previous Quarter
-25.2 M
Current Value
-37.3 M
Quarterly Volatility
7.7 M
 
Covid
Check X4 Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XFOR main balance sheet or income statement drivers, such as Interest Income of 3.5 M, Depreciation And Amortization of 3.6 M or Interest Expense of 3 M, as well as many exotic indicators such as Price To Sales Ratio of 40.66, Dividend Yield of 0.0 or PTB Ratio of 3.06. XFOR financial statements analysis is a perfect complement when working with X4 Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement X4 Pharmaceuticals' financial leverage analysis and stock options assessment as well as various X4 Pharmaceuticals Technical models . Check out the analysis of X4 Pharmaceuticals Correlation against competitors.
To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.

Latest X4 Pharmaceuticals' Ebit Growth Pattern

Below is the plot of the Ebit of X4 Pharmaceuticals over the last few years. It is X4 Pharmaceuticals' EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in X4 Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

XFOR Ebit Regression Statistics

Arithmetic Mean(44,433,260)
Coefficient Of Variation(80.26)
Mean Deviation30,309,512
Median(32,262,000)
Standard Deviation35,662,530
Sample Variance1271.8T
Range94.8M
R-Value(0.94)
Mean Square Error161.1T
R-Squared0.88
Slope(7,490,769)
Total Sum of Squares17805.4T

XFOR Ebit History

2024-102.1 M
2023-107.5 M
2022-87.6 M
2021-85.1 M
2020-59.9 M
2019-51.7 M
2018-42 M

Other Fundumenentals of X4 Pharmaceuticals

About X4 Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include X4 Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. X4 Pharmaceuticals investors use historical funamental indicators, such as X4 Pharmaceuticals's Ebit, to determine how well the company is positioned to perform in the future. Although X4 Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in X4 Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on X4 Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on X4 Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in X4 Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-107.5 M-102.1 M
EBITDA-105.5 M-100.2 M
Ebt Per Ebit 0.94  0.78 
Ebit Per Revenue(22.95)(24.10)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether X4 Pharmaceuticals is a strong investment it is important to analyze X4 Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact X4 Pharmaceuticals' future performance. For an informed investment choice regarding XFOR Stock, refer to the following important reports:
Check out the analysis of X4 Pharmaceuticals Correlation against competitors.
To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for XFOR Stock analysis

When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is X4 Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of X4 Pharmaceuticals. If investors know XFOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about X4 Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.67)
Return On Assets
(0.61)
Return On Equity
(4.89)
The market value of X4 Pharmaceuticals is measured differently than its book value, which is the value of XFOR that is recorded on the company's balance sheet. Investors also form their own opinion of X4 Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is X4 Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because X4 Pharmaceuticals' market value can be influenced by many factors that don't directly affect X4 Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between X4 Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if X4 Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, X4 Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.